irbesartan


Also found in: Medical, Wikipedia.

ir·be·sar·tan

 (ĭr′bə-sär′tn)
n.
An angiotensin II receptor blocker drug, C25H28 N6O, used to treat hypertension.

[irbe-, origin unknown + -sartan, angiotensin II receptor blocker suff.; see losartan.]
Translations

irbesartan

n irbesartán m
References in periodicals archive ?
Tenders are invited for Purchase of medicines Irbesartan 150,300 mg
evaluated the effects of the angiotensin II receptor blocker irbesartan given over 4 months in 60 patients with COPD and [FEV.
Up to 7 years after coronary artery bypass graft (CABG), the patient had no complaints of chest pain with his routine medications (aspirin 100 mg, clopidogrel 75 mg, irbesartan 150 mg, and amlodipine 5 mg once in a day).
Her medications were aripiprazole 5 mg daily, irbesartan 150 mg daily, amisulpride 150 mg daily, imipramine 50 mg nocte, lercanidipine 10 mg daily, and sertraline 300 mg daily.
Effect of irbesartan on streptozotocin induced diabetic nephropathy: an interventionary study.
The study achieved statistical significance in the primary efficacy endpoint for the overall sparsentan treatment group, demonstrating a greater than two-fold reduction of proteinuria compared to irbesartan after the eight-week treatment period.
5% for those (n=32) receiving 300 mg/day of irbesartan (p=0.
5 mg with irbesartan 300 mg every morning and * Add chlorthalidone 25 mg, 1/2 tablet every morning * Check basic metabolic panel after 1 mo * Increase chlorthalidone to 25 mg every morning * Check basic metabolic panel after 1 mo * Still not controlled?
To gain further insight into the mechanisms underlying RD beneficial effects, intracerebroventricular (icv) infusion of either AT1-R antagonist irbesartan (Irbe) or TNF-[alpha] inhibitor etanercept (ENT) during ISO administration was conducted to determine if these treatments could mimic the beneficial actions of RD.
A recent study investigated the role of CT-1 on atrial myocardial fibrosis in a canine model, and established that expression of CT-1 significantly increased in atrial fibrosis and irbesartan could decrease its expression [16].
The cyp2c9 genotype predicts the blood pressure response to irbesartan: Results from the swedish irbesartan left ventricular hypertrophy investigation vs atenolol (silvhia) trial.